BOD
Click for more information
0.00% 2.4¢ bod science limited

Ann: Phase IIB Clinical Trial of Schedule 3, page-10

  1. Keith2
    758 Posts.
    lightbulb Created with Sketch. 39
    clock Created with Sketch.
    17/07/23
    14:34
    Post #: 68825122
    i'd say we had alot of feedback from our medical cannabis which we prescribed through the SAS-B scheme, im sure they would gained a lot of data bout the side effects of the product,

    plus the difference is the amount of people we are testing, i think CAN tested 12 people where as we are testing 196 people. who knows, very exciting though
    Last edited by Keith2: 17/07/23
    BOD Price at posting: 9.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BOD (ASX) to my watchlist
(20min delay)
Last
2.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BOD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.